Experimental evidence demonstrates significant membrane density increases in both SGLT isoforms in diabetic rodent models [18,19], a finding corroborated in human studies showing elevated SGLT2 mRNA/protein expression in urinary tubular cells from T2DM patients [20]. Here, SLC5A2 is linked to type 2 diabetes mellitus.